Vinva Investment Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.7M Buy
292,684
+55,838
+24% +$3.03M 0.08% 192
2026
Q1
$14.9M Buy
236,846
+18,943
+9% +$1.52M 0.18% 126
2025
Q4
$20.9M Buy
217,903
+93,143
+75% +$9.13M 0.26% 98
2025
Q3
$12.1M Buy
124,760
+56,645
+83% +$5.87M 0.24% 109
2025
Q2
$7.26M Buy
68,115
+13,444
+25% +$1.36M 0.19% 134
2025
Q1
$5.43M Buy
54,671
+7,182
+15% +$723K 0.22% 123
2024
Q4
$4.26M Sell
47,489
-4,586
-9% -$404K 0.16% 142
2024
Q3
$4.34M Sell
52,075
-6,469
-11% -$510K 0.18% 128
2024
Q2
$4.51M Buy
58,544
+2,694
+5% +$197K 0.23% 111
2024
Q1
$3.83M Buy
55,850
+5,235
+10% +$337K 0.21% 124
2023
Q4
$2.85M Buy
50,615
+8,767
+21% +$468K 0.19% 132
2023
Q3
$2.23M Sell
41,848
-739
-2% -$38.8K 0.21% 116
2023
Q2
$2.27M Sell
42,587
-5,907
-12% -$309K 0.2% 127
2023
Q1
$2.41M Buy
+48,494
New +$2.29M 0.2% 131

Other funds holding BSX

Vinva Investment Management's BSX Position: Q2 2026 in Review

Vinva Investment Management increased its Boston Scientific (BSX) stake by 24% in Q2 2026, buying an estimated $3.03M and bringing the position to 292,684 shares worth $12.7M. The position accounts for 0.08% of the portfolio, ranked #192.

Vinva Investment Management first reported a position in BSX in Q1 2023 and has held it in 14 quarters since. The position peaked at $20.9M in Q4 2025. 1,474 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Vinva Investment Management held 292,684 shares of Boston Scientific worth $12.7M as of Q2 2026.
  • Vinva Investment Management bought 55,838 Boston Scientific shares in Q2 2026, an estimated $3.03M.
  • Boston Scientific made up 0.08% of Vinva Investment Management's portfolio in Q2 2026, its #192 holding.
  • Vinva Investment Management first reported a position in Boston Scientific in Q1 2023 and has held it in 14 quarters since.
  • Vinva Investment Management's Boston Scientific position peaked at $20.9M in Q4 2025.
  • 1,474 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Vinva Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.